Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,323 GBX | +0.48% | +1.22% | +16.08% |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.08% | 238B | |
+34.19% | 698B | |
+26.51% | 568B | |
-4.63% | 358B | |
+18.73% | 328B | |
+3.82% | 283B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.74% | 165B | |
-4.64% | 160B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024